| Journal | Children (Basel, Switzerland) |
| Study Type | Clinical Study |
| Population | Human participants |
Adolescent substance use and suicidality represent intersecting clinical crises requiring evidence-based risk stratification. Understanding comparative risk factors across different substances informs both prevention strategies and acute clinical decision-making in pediatric and family practice settings.
This clinical study examined psychosocial and clinical risk factors associated with suicide attempts among adolescents with substance use disorders, comparing patterns across different substance categories. The research analyzed clinical presentations, demographic factors, and psychosocial variables to identify differential risk profiles. While the study provides valuable descriptive data on this vulnerable population, the observational design limits causal inferences about substance-specific suicide risk mechanisms.
“I see adolescents with cannabis use disorders regularly, and this type of comparative risk analysis helps contextualize cannabis within the broader spectrum of adolescent substance use and mental health comorbidity. The data reinforces that no substance use in adolescence occurs in isolation from other risk factors.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Is cannabis use associated with increased suicide risk in adolescents?
- Should I screen adolescent patients for both substance use and suicidal ideation together?
- What clinical red flags should I watch for in adolescent cannabis users?
- How should I approach treatment when an adolescent has both cannabis use and suicide risk?
- Can I use this evidence to make definitive clinical decisions about cannabis and suicide risk?
FAQ
Is cannabis use associated with increased suicide risk in adolescents?
This study indicates there may be an association between substance use, including cannabis, and suicide attempts in adolescents. However, the evidence is still emerging and requires further research to establish causality and determine the strength of this relationship.
Should I screen adolescent patients for both substance use and suicidal ideation together?
Yes, this research supports the importance of comprehensive screening that addresses both substance use and mental health concerns simultaneously. The co-occurrence of these risk factors suggests they should be evaluated together during adolescent assessments.
What clinical red flags should I watch for in adolescent cannabis users?
Clinicians should monitor for signs of depression, social isolation, changes in academic performance, and any expressions of hopelessness or suicidal thoughts. The combination of cannabis use with these psychosocial factors may indicate elevated risk.
How should I approach treatment when an adolescent has both cannabis use and suicide risk?
A coordinated approach addressing both issues simultaneously is recommended, as they appear to be interconnected. Treatment should include mental health support, substance abuse counseling, and close monitoring with appropriate safety planning.
Can I use this evidence to make definitive clinical decisions about cannabis and suicide risk?
This study provides early-stage evidence that requires further validation before making definitive clinical decisions. Use this information to inform risk assessment and monitoring strategies while awaiting more robust research findings.